Manage Your Liver
Q:

What is NCD? What problem is it causing? How can the problem be solved?

A:

NCD stands for non-communicable disease, also known as “lifestyle disease”. This type of diseases are not passed from person to person. They are usually chronic diseases that progress slowly throughout a long period of time. NCDs are preventable and the most common causes are smoking, alcohol abuse, unbalanced diets and lack of physical activity. According to WHO, NCD nowadays overtook infectious diseases as the principle driver of global mortality.

 

The 4 main types of NCDs are cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. They account for over 80% of all NCD deaths. [1]

 

The rise of NCDs has brought serious socioeconomic impacts. High health care costs for treating NCDs not only become a heavy burden for governments but also drive families into poverty. Premature deaths (death before the age of 70) are also increasing globally and most occur in middle and low-income countries. This is mainly because developing countries generally have lower capacity for the prevention and control of NCDs. Although high-income groups also suffer from unhealthy diet and lifestyle, they can access better medical services and products that can protect them. On the contrary, some of these treatments are simply unaffordable for the less privileged.

Dealing with NCDs requires effort from both individuals and governments. The individual must adopt behavior changes and lead a healthy lifestyle in order to minimize the risk of NCDs. However, it is up to the governments to develop policies and revolutionize public health care to tackle the core of this problem. NCDs are driven by the effects of globalization, rapid urbanization and population ageing – factors over which the individual has little control and over which the conventional health sector also has little power.

World Health Organization (WHO) has recommended a set of low-cost policy interventions that focus on two main aspects: prevention and detection. [2]

 

Prevention

To lessen the NCD burden, WHO put forward a global action plan that aims to reduce the number of premature deaths through nine global targets. The targets include to reduce alcohol abuse, insufficient physical activity, salt/sodium intake, tobacco use and hypertension; halt the rise of obesity and diabetes; and improve coverage of treatment for the prevention of cardiovascular diseases and access to basic technologies and medicines. Some of the suggested measures include banning all forms of tobacco and alcohol advertising, replacing trans fats with polyunsaturated fats and promoting breastfeeding.

Apart from the above, we also recommend people to maintain their liver and kidney health, as normal liver and kidney functions are closely linked with preventing modern diseases. 

 

Detection

“Disease surveillance is further needed to detect NCDs and to detect them early, when patient management has the best chance of success and at the lowest cost.” – Dr. Margaret Chan, WHO Director-General [3]

Regular checkups and screening is important as early detection and diagnosis can result in timely treatment of NCDs. The success rate of treatment is higher and treatment is more cost-effective in the early stages. WHO also recommends the development of more user-friendly technologies for easy diagnosis by health workers and self-monitoring by patients for diseases such as hypertension and diabetes.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
In a recent study published in Scientific Reports, experts have warned that the common over-the-counter painkiller could be as bad for your liver as cancer.   Paracetamol or acetaminophen (you may recognize it as Tylenol) overdose can damage liver tissue structure. Dr Leonard Nelson from the University of Edinburgh, who co-led the study, said: "Paracetamol is the world's preferred pain remedy - it is cheap, and considered safe and effective at therapeuti
A:
Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. NAFLD is one of the most common causes of liver disease in the United States. Between 30 and 40 percent of adults in the United States have NAFLD. About 3 to 12 percent of adults in the United States have NASH (a form of NAFLD in which you have inflammation and liver cell damage). [1] Recent research found that NAFLD not only increases the risk of chronic liver diseases such as NASH, l
Hit Questions
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us